News
"I was a very healthy person; I ate well, worked out often and took care of my husband. Then all of a sudden, I couldn't do anything for myself." ...
1d
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic ...
GSK is witnessing increased sales growth of its Specialty Medicines unit, a trend expected to continue through the rest of 2025.
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya (pivmecillinam ...
Pivmecillinam proved highly effective in treating uUTIs, with trial reanalysis supporting its FDA approval after decades of ...
Doctors and scientists are hopeful that the non-antibiotic treatment could ultimately help millions of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results